SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J Stone who wrote (443)10/13/1998 10:31:00 AM
From: Karl Drobnic  Read Replies (2) of 706
 
I agree - the conference call was mostly a repeat of the Press Release. Medical questions seemed well-handled by the medical experts they had available. Questions about sales, production, distribution, funding, etc. were mainly answered with jargon and safe-harbor style statements. My impression was that BLTI wanted to talk about and publicize the FDA approval, not talk about investment matters. I expected them to have a better statement ready to address US distribution. They said that they had immediate orders ready to ship for Millenium. I had the impression of units sitting on the loading dock waiting for the truck. But it could have also been orders in a file cabinet ready to go into production. It was difficult to get quantified information, but I think the purpose was to celebrate FDA approval, not report on the fundamentals.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News